SEC Filings | Caribou Biosciences, Inc.

Form	Description	Filing date	View
CORRESP	CORRESP	July 1, 2021	0001193125-21-206273.pdf 0001193125-21-206273.rtf 0001193125-21-206273.xls View HTML
UPLOAD	UPLOAD	June 23, 2021	0000000000-21-007723.pdf 0000000000-21-007723.rtf View HTML
DRS/A	Amendment to a previously filed DRS	June 11, 2021	0000950123-21-007771.pdf 0000950123-21-007771.rtf 0000950123-21-007771.xls View HTML
UPLOAD	UPLOAD	June 2, 2021	0000000000-21-006847.pdf 0000000000-21-006847.rtf View HTML
DRS	Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy	May 7, 2021	0000950123-21-005591.pdf 0000950123-21-005591.rtf 0000950123-21-005591.xls View HTML
D	Notice of Exempt Offering of Securities	March 5, 2021	0001619856-21-000002.pdf 0001619856-21-000002.rtf 0001619856-21-000002.xls View HTML
SC 13G/A	An amendment to the SC 13G filing	March 25, 2019	0001654954-19-003213.pdf 0001654954-19-003213.rtf 0001654954-19-003213.xls View HTML
SC 13G/A	An amendment to the SC 13G filing	January 16, 2019	0001654954-19-000534.pdf 0001654954-19-000534.rtf 0001654954-19-000534.xls View HTML
4	Statement of changes in beneficial ownership of securities	January 30, 2018	0001415889-18-000152.pdf 0001415889-18-000152.rtf 0001415889-18-000152.xls View HTML
4	Statement of changes in beneficial ownership of securities	September 13, 2017	0001415889-17-001484.pdf 0001415889-17-001484.rtf 0001415889-17-001484.xls View HTML

Data provided by Kaleidoscope.